Literature DB >> 27452612

Zinc Levels in Left Ventricular Hypertrophy.

Lei Huang1, Tianming Teng1, Bo Bian1, Wei Yao1, Xuefang Yu1, Zhuoqun Wang1, Zhelong Xu2, Yuemin Sun3.   

Abstract

Zinc is one of the most important trace elements in the body and zinc homeostasis plays a critical role in maintaining cellular structure and function. Zinc dyshomeostasis can lead to many diseases, such as cardiovascular disease. Our aim was to investigate whether there is a relationship between zinc and left ventricular hypertrophy (LVH). A total of 519 patients was enrolled and their serum zinc levels were measured in this study. We performed analyses on the relationship between zinc levels and LVH and the four LV geometry pattern patients: normal LV geometry, concentric remodeling, eccentric LVH, and concentric LVH. We performed further linear and multiple regression analyses to confirm the relationship between zinc and left ventricular mass (LVM), left ventricular mass index (LVMI), and relative wall thickness (RWT). Our data showed that zinc levels were 710.2 ± 243.0 μg/L in the control group and were 641.9 ± 215.2 μg/L in LVH patients. We observed that zinc levels were 715 ± 243.5 μg/L, 694.2 ± 242.7 μg/L, 643.7 ± 225.0 μg/L, and 638.7 ± 197.0 μg/L in normal LV geometry, concentric remodeling, eccentric LVH, and concentric LVH patients, respectively. We further found that there was a significant inverse linear relationship between zinc and LVM (p = 0.001) and LVMI (p = 0.000) but did not show a significant relationship with RWT (p = 0.561). Multiple regression analyses confirmed that the linear relationship between zinc and LVM and LVMI remained inversely significant. The present study revealed that serum zinc levels were significantly decreased in the LVH patients, especially in the eccentric LVH and concentric LVH patients. Furthermore, zinc levels were significantly inversely correlated with LVM and LVMI.

Entities:  

Keywords:  Left ventricular hypertrophy (LVH); Left ventricular mass (LVM); Left ventricular mass index (LVMI); Zinc

Mesh:

Substances:

Year:  2016        PMID: 27452612     DOI: 10.1007/s12011-016-0808-y

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  5 in total

Review 1.  Zinc as a Biomarker of Cardiovascular Health.

Authors:  Marija Knez; Maria Glibetic
Journal:  Front Nutr       Date:  2021-07-30

2.  No Association of Hair Zinc Concentration with Coronary Artery Disease Severity and No Relation with Acute Coronary Syndromes.

Authors:  Ewelina A Dziedzic; Jakub S Gąsior; Agnieszka Tuzimek; Justyna Paleczny; Mirosław Kwaśny; Marek Dąbrowski; Piotr Jankowski
Journal:  Biomolecules       Date:  2022-06-21

3.  Association between Reduced Serum Zinc and Diastolic Dysfunction in Maintenance Hemodialysis Patients.

Authors:  Jiun-Chi Huang; Ya-Chin Huang; Pei-Yu Wu; Wen-Hsien Lee; Yi-Chun Tsai; Yi-Ping Chen; Szu-Chia Chen; Ho-Ming Su; Yi-Wen Chiu; Jer-Ming Chang
Journal:  Nutrients       Date:  2021-06-17       Impact factor: 5.717

4.  An association between N-terminal pro-brain natriuretic protein level and risk of left ventricular hypertrophy in patients without heart failure.

Authors:  Lei Huang; Longfei Huang; Jing Yu; Xianming Wu; Jinyan Zhao
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

Review 5.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.